Literature DB >> 23860440

Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis.

K L Moffitt1, S L Martin1, A M Jones2, A K Webb2, C Cardwell3, M M Tunney1, J S Elborn4.   

Abstract

BACKGROUND: Chronic Pseudomonas aeruginosa pulmonary infection is associated with a decline in lung function and reduced survival in people with Cystic Fibrosis (CF). Damaging inflammatory and immunological mediators released in the lungs can be used as markers of chronic infection, inflammation and lung tissue damage.
METHODS: Clinical samples were collected from CF patients and healthy controls. Serum IgG and IgA anti-Pseudomonas antibodies, sputum IL-8 and TNFα, plasma IL-6 and urine TNFr1 were measured by ELISA. Sputum neutrophil elastase (NE), cathepsin S and cathepsin B were measured by spectrophotometric and fluorogenic assays. The relationship between IgG and IgA, inflammatory mediators and long-term survival was determined.
RESULTS: IgG and IL-6 positively correlated with mortality. However, multivariate analysis demonstrated that after adjusting for FEV(1), IgG was not independently related to mortality. A relationship was observed between IgG and IL-6, TNFα, TNFr1 and between IgA and IL8, cathepsin S and cathepsin B.
CONCLUSIONS: These data indicate that biomarkers of inflammation are not independent predictors of survival in people with CF.
© 2013.

Entities:  

Keywords:  Antibody titre; Cystic Fibrosis; Inflammation; Mortality; Proteases; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2013        PMID: 23860440     DOI: 10.1016/j.jcf.2013.06.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  4 in total

1.  Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures.

Authors:  Chong Da Tan; Carey Hobbs; Mansoureh Sameni; Bonnie F Sloane; M Jackson Stutts; Robert Tarran
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

2.  Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis.

Authors:  Li Zhang; Xiao-Hong Fu; Yong Yu; Ruo-Hong Shui; Chun Li; Hai-Ying Zeng; Yu-Lei Qiao; Li-Yan Ni; Qiang Wang
Journal:  Lab Invest       Date:  2014-11-10       Impact factor: 5.662

3.  Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia.

Authors:  Ruth Duecker; Patrick Baer; Olaf Eickmeier; Maja Strecker; Jennifer Kurz; Alexander Schaible; Dirk Henrich; Stefan Zielen; Ralf Schubert
Journal:  Redox Biol       Date:  2017-11-10       Impact factor: 11.799

4.  Elevated IgG4 serum levels in patients with cystic fibrosis.

Authors:  Axelle Clerc; Quitterie Reynaud; Stéphane Durupt; Colette Chapuis-Cellier; Raphaële Nové-Josserand; Isabelle Durieu; Jean Christophe Lega
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.